330 related articles for article (PubMed ID: 38675959)
1. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
Songtanin B; Chaisrimaneepan N; Mendóza R; Nugent K
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675959
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis D: A Review.
Negro F; Lok AS
JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
[TBL] [Abstract][Full Text] [Related]
3. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.
Lavanchy D
J Viral Hepat; 2004 Mar; 11(2):97-107. PubMed ID: 14996343
[TBL] [Abstract][Full Text] [Related]
5. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.
Tawada A; Kanda T; Imazeki F; Yokosuka O
Hepatol Int; 2016 Jul; 10(4):574-93. PubMed ID: 27026375
[TBL] [Abstract][Full Text] [Related]
8. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Allaire M; Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; DI Martino V; Sutton A; Letouzé E; Audureau E; Roudot-Thoraval F;
Hepatology; 2018 Oct; 68(4):1245-1259. PubMed ID: 29663511
[TBL] [Abstract][Full Text] [Related]
9. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
Iloeje UH; Yang HI; Chen CJ
Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
[TBL] [Abstract][Full Text] [Related]
10. Correlation between hepatitis B virus genotypes and clinical outcomes.
Shi YH
Jpn J Infect Dis; 2012; 65(6):476-82. PubMed ID: 23183198
[TBL] [Abstract][Full Text] [Related]
11. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
Tseng TC; Liu CJ; Chang CT; Su TH; Yang WT; Tsai CH; Chen CL; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
J Hepatol; 2020 Jun; 72(6):1105-1111. PubMed ID: 32006586
[TBL] [Abstract][Full Text] [Related]
12. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
13. Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study.
Xie J; Wang X; Wang X; Li J; Jie Y; Hao Y; Gu J
Glob Health Res Policy; 2024 Jan; 9(1):5. PubMed ID: 38246986
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection.
McGovern BH
Antivir Ther; 2007; 12 Suppl 3():H3-13. PubMed ID: 18284178
[TBL] [Abstract][Full Text] [Related]
15. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
17. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025.
Nguyen VT; Law MG; Dore GJ
Liver Int; 2008 Apr; 28(4):525-31. PubMed ID: 18266635
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
19. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
20. The current and future burden of hepatitis B in Switzerland: a modelling study.
Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D
Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
